News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
DexCom Appoints Jonathan Lord, M.D. as Board Member
May 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO--(BUSINESS WIRE)--DexCom Inc. (NASDAQ:DXCM) today announced the appointment of Jonathan T. Lord, M.D. as a member of DexCom’s Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Earnings
Biogen’s ‘Bridge To Growth’ Cuts Through a Stacked Phase 3 Pipeline
February 6, 2026
·
2 min read
·
Annalee Armstrong
IPO
Eikon Clocks Largest IPO Since 2024, Generate, AgomAb Follow
February 6, 2026
·
5 min read
·
Tristan Manalac
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
Editorial
Novo Will Never Beat Lilly. Why Does It Have To?
February 5, 2026
·
3 min read
·
Annalee Armstrong